Advanced (Inoperable) Non Small Cell Lung Cancer Active Not Recruiting Phase 1 Trials for Itraconazole (DB01167)

IndicationStatusPhase
DBCOND0061745 (Advanced (Inoperable) Non Small Cell Lung Cancer)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02157883Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)Other